Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.

[1]  L. Mariani,et al.  Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group , 1996, Cancer.

[2]  B. Taal,et al.  Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group. , 1995, British Journal of Cancer.

[3]  N. Kemeny,et al.  A phase II trial of alpha‐interferon and 5‐fluorouracil in patients with advanced carcinoid and islet cell tumors , 1994, Cancer.

[4]  T. Fleming,et al.  Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid , 1994, Cancer.

[5]  R. Labianca,et al.  Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon‐alpha‐2a: A study by the Italian trials in Medical Oncology Group , 1993, Cancer.

[6]  L. Saltz,et al.  A phase II trial of carboplatin in patients with advanced APUD tumors , 1993, Cancer.

[7]  A. Einstein,et al.  Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Lipsitz,et al.  Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. , 1992, The New England journal of medicine.

[9]  M. Ducreux,et al.  Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin. , 1991, European journal of cancer.

[10]  R. Prinz,et al.  DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors. , 1987, Surgery.

[11]  J. Hanley,et al.  Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. , 1980, The New England journal of medicine.

[12]  D. Farquhar,et al.  Mechanism of action and pharmacology studies with DTIC (NSC-45388). , 1976, Cancer treatment reports.

[13]  A. Kessinger,et al.  Use of DTIC in the malignant carcinoid syndrome. , 1977, Cancer treatment reports.